Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort

PURPOSE: Although clopidogrel is the most widely used oral P2Y12 receptor antagonist, up to 10% of acute coronary syndrome patients treated with clopidogrel will experience a recurrent myocardial infarction and 2–3% will experience stent thrombosis within 1 year. The purpose of this research is to d...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacogenomics
Main Authors: Melin, Kyle, Moon, Jee-Young, Qi, Qibin, Hernandez-Suarez, Dagmar F, Duconge, Jorge, Hua, Simin, Gonzalez, Sara, Zeng, Donglin, Kaplan, Robert C
Format: Artigo
Language:Inglês
Published: Future Medicine Ltd 2019
Subjects:
Short Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6462835/
https://ncbi.nlm.nih.gov/pubmed/30520344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2018-0148
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items